✦ LIBER ✦

Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma in Need of Palliative Therapy

✍ Scribed by Kaplan, Lawrence D.; Deitcher, Steven R.; Silverman, Jeffrey A.; Morgan, Gareth

Book ID: 123360030
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 203 KB
Volume: 14
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I/II Study of a Hybrid Schedule

A Phase I/II Study of a Hybrid Schedule of Flavopiridol in Relapsed/Refractory Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

✍ Kieron Dunleavy; Geoff Shapiro; Megan Disinski; Lucian Chirieac; Stefania Pittal 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 47 KB

Pilot study of dacetuzumab in combinatio

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

✍ Forero-Torres, Andres; Bartlett, Nancy; Beaven, Anne; Myint, Han; Nasta, Sunita; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 269 KB

Combination of Lenalidomide and Rituxima

Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial

✍ Pier Luigi Zinzani; Cinzia Pellegrini; Letizia Gandolfi; Vittorio Stefoni; Feder 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 281 KB

Multicentre phase II study of CyclOBEAP

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohri; Yuki Hagiwara; Ken Tanae; Naoki Takahashi; Masami Bes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The R‐CHOP regimen has been found to improve the outcome of diffuse large B‐cell lymphoma (DLBCL). However, it does not provide a satisfactory treatment outcome in the high‐risk group. We previously administered the CyclOBEAP regimen to patients with DLBCL, and reported its safety and e

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Phase II study of the CPT-11, mitoxantro

Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohuri; Masaaki Higashihara; Masami Bessho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB